Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Recipients.
Tom A YatesNeil HallidayPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)